Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation (Q40107032)

17 September 2017

title

Pramlintide Antagonizes Beta Amyloid (Aβ)- and Human Amylin-Induced Depression of Hippocampal Long-Term Potentiation (English)

1 reference

17 September 2017

main subject

long-term potentiation

1 reference

R Kimura

1

1 reference

17 September 2017

D MacTavish

2

1 reference

17 September 2017

J Yang

3

1 reference

17 September 2017

D Westaway

4

1 reference

17 September 2017

Jack H Jhamandas

5

1 reference

17 September 2017

language of work or name

1 reference

15 January 2016

1 reference

17 September 2017

published in

Molecular Neurobiology

1 reference

17 September 2017

volume

54

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

748-754

1 reference

Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Normal and abnormal biology of the beta-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

The therapeutics of Alzheimer's disease: where we stand and where we are heading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

The amyloid hypothesis for Alzheimer's disease: a critical reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Antagonist of the amylin receptor blocks beta-amyloid toxicity in rat cholinergic basal forebrain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Actions of β-amyloid protein on human neurons are expressed through the amylin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

21 January 2018

Receptor pharmacology

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

β-Amyloid protein (Aβ) and human amylin regulation of apoptotic genes occurs through the amylin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Attenuation of the anorectic effects of cholecystokinin and bombesin by the specific amylin antagonist AC 253.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Protective effects of amylin on reserpine-induced gastric damage in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

Rationally designed, nontoxic, nonamyloidogenic analogues of human islet amyloid polypeptide with improved solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12035-016-9684-X

The value of transgenic models for the study of neurodegenerative diseases

21 January 2018

1 reference

12 December 2020

Activity of Pramlintide, Rat and Human Amylin but not Aβ1–42at Human Amylin Receptors

1 reference

12 December 2020

Alzheimer mechanisms and therapeutic strategies

1 reference

12 December 2020

Amyloid β (Aβ) peptide directly activates amylin-3 receptor subtype by triggering multiple intracellular signaling pathways

1 reference

12 December 2020

Lessons from two prevalent amyloidoses-what amylin and Aβ have in common

1 reference

12 December 2020

10.1007/S12035-016-9684-X

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

1000389235

0 references

1 reference